IPO Guru
Bajaj
Listed

Brooks Laboratories IPO GMP History

Brooks Laboratories IPO has been listed on September 5, 2011 at a listing price of ₹100, against the issue price of ₹100 — a gain of ₹0 (+0%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.

Brooks Laboratories IPO raised ₹63 Cr. through its IPO at a price band of ₹90 to ₹100 per share, with a lot size of 60 shares. The IPO was open for subscription from 16 Aug 2011 to 18 Aug 2011.

Abhishek Vohera, Founder of IPO Guru Researched & reviewed by Abhishek Vohera, Founder, IPO Guru Last updated Figures sourced from the RHP, BSE & NSE

GMP trend

Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 12 Nov, 3:10 PM IST.

Peak GMP
--
No readings yet
Lowest GMP
--
No readings yet
Direction
— stable
Needs two days of GMP
The chart appears once the grey market starts quoting Brooks Laboratories IPO.

Day-wise GMP

The last reading of each day, newest first. Arrows compare with the previous day.

Date GMP ↑↓ % Kostak Sub. Sauda
No GMP history available yet.

Brooks Laboratories IPO dates

Key dates from opening to listing. Today is 22 November.

Key dates Listed
  1. Open 16 Aug 2011
  2. Close 18 Aug 2011
  3. Allotment 26 Aug 2011
  4. Refund/credit TBA
  5. Listing 05 Sep 2011

Brooks Laboratories IPO actual listing price

How the grey market's final call compared with the listing-day open.

Issue price₹100
Listing gain / loss +₹0 per share
Listing date05 Sep, 2011
Actual listing price ₹100 (+0%)

Is Brooks Laboratories IPO GMP reliable?

Grey market premium for Brooks Laboratories IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:

  • 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
  • 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
  • 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
  • 04Cross-check before acting: Review the Brooks Laboratories IPO full review for a fundamentals-based assessment before making any grey market trades.

Brooks Laboratories IPO Kostak rate explained

Two ways the grey market trades an IPO application before listing.

Kostak
Not available

The Kostak rate for Brooks Laboratories IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.

Subject to Sauda
Not available

The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.

Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.

About Brooks Laboratories IPO

Brooks Laboratories Limited works in pharmaceutical contract research and manufacturing. Its promoters are Atul Ranchal and Rajesh Mahajan.

It makes a wide range of products for the critical care segment, including beta lactam, cephalosporin and general dry powder injectables, ampoules and liquid vials, dry syrups and tablets.

Its manufacturing unit is at Baddi in Himachal Pradesh.

The IPO was Rs 63 crore and was entirely fresh issue at Rs 100, the top of the Rs 90 to Rs 100 band. Most of the money was for a new plant, covering land, buildings, machinery and utilities.

View full IPO details →

Frequently asked

What is the GMP of Brooks Laboratories IPO?

The current Grey Market Premium (GMP) of Brooks Laboratories IPO is not yet started or active in the market.

What is the Kostak Price of Brooks Laboratories IPO?

Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Brooks Laboratories IPO is not available.

What is the Subject to Sauda Price of Brooks Laboratories IPO?

Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.

What was the actual listing price of Brooks Laboratories IPO?

Brooks Laboratories IPO listed on September 5, 2011 at ₹100, against the issue price of ₹100 — a gain of +0%.

How did the GMP of Brooks Laboratories IPO trend before listing?

The GMP of Brooks Laboratories IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.

Explore Brooks Laboratories IPO further

The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.

Brooks Laboratories IPO GMP

The grey market called it. Now check the fundamentals.

IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.

Join the WhatsApp channel All live IPO GMP

Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.

GMP
₹ 0
Kostak
—
Listed at
₹100
Full IPO details
Advertisement